ELV Elevance Health, Inc. Common Stock
Sobre Elevance Health, Inc. Common Stock Visão geral da empresa da Wikipedia
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.
Ler mais
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.
Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing (BPO)/Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States.
History
Anthem
In 1946, Anthem began in Indianapolis, Indiana, as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. The companies grew significantly, controlling 80% of the medical insurance market in Indiana by the 1970s.
In 1972, the two firms, then known as Blue Cross of Indiana and Blue Shield of Indiana, entered into a joint operating agreement.
In 1985, the two companies merged into Associated Insurance Companies, Inc,, later called, The Associated Group, a holding company, but usage of the name "Anthem" persisted. In 1989, the company purchased American General Insurance Co. for $150 million and in 1991, it acquired The Shelby Insurance Co., based in Shelby, Ohio, for $125 million. In 1989, The Associated Group founded Acordia, a brokerage that sold and serviced insurance and employee benefit programs.
In 1993, Acordia acquired American Business Insurance for $130 million and the Federal Kemper Insurance Company for $100 million. The Associated Group merged with Southeastern Mutual Insurance Company, the operator of Blue Cross and Blue Shield of Kentucky. In 1994, it sold Raffensperger, Hughes & Co., Inc., Indiana's largest investment bank, to National City Corp.
In 1995, The Associated Group acquired Community Mutual Insurance, a provider of Blue Cross and Blue Shield insurance plans in Ohio with over 1.9 million policy holders), then set up Anthem Blue Cross and Blue Shield. In 1996, The Associated Group changed its name to Anthem Insurance Company. In August 1997, Anthem acquired Blue Cross and Blue Shield of Connecticut. It also sold Acordia to management.
In 1999, Anthem acquired Blue Cross and Blue Shield of New Hampshire and Blue Cross and Blue Shield of Colorado and Nevada, using debt financing. The acquisitions made since 1996 added 850,000 policy holders. Among its customer base were 2.4 million PPO and 964,000 HMO enrollees.
In 2000, Anthem acquired Blue Cross Blue Shield of Maine. The Gramm-Leach-Bliley Act of 1999 made it possible for Anthem to undergo demutualization and become a public company via an initial public offering, which made it the fourth largest public managed health care company in the United States.
In 2002, Anthem acquired Trigon Healthcare of Virginia, a Blue Cross and Blue Shield plan, the largest insurer in Virginia, for $4.04 billion. Anthem Insurance Company reached 11.9 million members.
Blue Cross of California
Blue Cross of California was the predecessor of WellPoint Health Network Inc.
In 1982, Blue Cross of California was founded with the consolidation of Blue Cross of Northern California (established in 1936) and Blue Cross of Southern California (established in 1937).
In 1992, WellPoint was formed to operate Blue Cross of California's managed care business. In January 1993, Blue Cross of California spun off its managed care business into a publicly traded entity, WellPoint Health Networks Inc. Blue Cross of California retained an 80% interest and voting control.
In 1996, Blue Cross of California restructured to a for-profit corporation, designating WellPoint Health Networks Inc. as the parent organization. In April 1996, WellPoint completed its acquisition of Massachusetts Mutual Life Insurance Company's group life and health insurance subsidiaries for approximately $380 million, making it the second largest publicly held managed health company in the U.S. with 4 million policyholders.
In March 1997, WellPoint acquired the group health and life businesses of John Hancock Financial for $86.7 million. With this acquisition, WellPoint expanded its presence into Michigan, Texas, and the mid-Atlantic, and gained a unit that concentrated on serving the needs of large employers.
In 2000, WellPoint acquired PrecisionRx, a mail service pharmacy fulfillment center in Texas. In March 2000, WellPoint acquired Rush Prudential Health Plans, a Chicago provider, for $204 million. In March 2001, WellPoint acquired Cerulean Companies, the parent company of Blue Cross Blue Shield of Georgia. In 2001, WellPoint offered to acquire CareFirst BlueCross BlueShield for $1.37 billion, including $119 million in bonuses to Carefirst executives. In 2003, the offer was rejected by the Maryland insurance commissioner.
In 2002, WellPoint acquired RightChoice Managed Care, a Missouri-based company that ran Blue Cross and Blue Shield for part of the state, for $1.5 billion. RightChoice also owned provider network company HealthLink. WellPoint also acquired MethodistCare of Houston, Texas and HealthLink. In 2003, WellPoint acquired Golden West Dental and Vision of Camarillo, California, and Cobalt, including Blue Cross and Blue Shield United of Wisconsin.
In November 2004, Wellpoint, Inc. was formed by the merger of Anthem Insurance Company and WellPoint Health Networks Inc. The merger was structured as Anthem acquiring WellPoint Health Networks and renaming itself WellPoint, Inc. WellPoint continued to use 'Anthem' as the brand name under which it operated. It sold its Blue Cross and Blue Shield products in 11 states.
In 2005, WellPoint acquired Alexandria, Virginia–based Lumenos, a provider of consumer-driven health care, for $185 million. Lumenos was the pioneer and market leader in consumer-driven health plans. In December, WellPoint acquired WellChoice, a New York City-based Blue Cross Blue Shield provider, for approximately $6.5 billion, making New York the 14th state in which WellPoint is a Blue Cross Blue Shield licensee.
In 2007, WellPoint acquired Chicago-based American Imaging Management, a radiology benefit management company that creates software to help physicians choose cost-effective locations for their patients to receive medical imaging tests. WellPoint also acquired Chicago-based American Imaging Management (AIM), the leading radiology benefit management company.
In January 2008, Leslie Margolin became the president of California operations. She resigned in July 2010. In 2008, WellPoint acquired Resolution Health, a firm that analyzes patient history for potential medical problems such as adverse drug interactions. In 2009, WellPoint acquired DeCare Dental, a dental insurance firm.
In 2011, WellPoint acquired CareMore, a Cerritos, California-based provider of insurance and care centers for elderly patients. In 2012, WellPoint acquired Amerigroup for $4.9 billion, anticipating significant growth due to Medicaid expansion under the Patient Protection and Affordable Care Act. In August 2012, CEO Angela Braly resigned due to pressure from investors.
On August 13, 2014, WellPoint announced it intended to change its name to Anthem, Inc., effective in December.
Anthem, Inc.
In February 2015, the company acquired Simply Healthcare Holdings, a Medicaid and Medicare managed care company based in Florida. In June 2015, Anthem made an offer to acquire Cigna for more than $54 billion in cash and stock. In February 2017, United States district court Judge Amy Berman Jackson blocked the Cigna merger on grounds of anti-competitive practices. On February 14, Cigna called off its merger agreement with Anthem.
In October 2017, Anthem announced that it would not renew its pharmacy benefit management (PBM) relationship with Express Scripts saying it had been overcharged $3 billion and that instead, Anthem would eventually handle the PBM process itself through its new IngenioRx unit. Anthem announced that it would enter a 5-year contract with CVS Health. Cigna then announced plans in March 2018 to acquire Express Scripts for $58 billion. On November 6, 2017, Gail Koziara Boudreaux was named CEO. In 2018, the company announced a $20 million expansion of its headquarters and the signing of a lease in Atlanta for its technology center. In March 2020, Anthem announced the acquisition of Beacon Health Options, and independently held behavioral health organization.
On February 2, 2021, Anthem announced the acquisition of InnovaCare Health's Puerto Rico subsidiaries including MMM Holdings, LLC ("MMM") and its Medicare Advantage (MA) plan MMM Healthcare, LLC as well as affiliated companies and Medicaid plan. In November 2021, Anthem announced the acquisition of Integra Managed Care in New York. The acquisition of the New York-based international health insurance company was completed on May 5, 2022.
On June 28, 2022, Anthem announced a change of its corporate name to Elevance Health, Inc. and also changed its stock ticker symbol from "ANTM" to "ELV".
Elevance Health
On January 23, 2023, Elevance announced that it entered a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana, increasing Elevance's footprint to 15 states and adding 1.9 million new members. In 2023, Elevance announced that it would rebrand its Amerigroup business as Wellpoint starting in 2024.
As of 2025, Elevance subsidiaries Carelon Behavioral Health and Anthem Blue Cross and Blue Shield are the subject of three lawsuits in New York and Connecticut alleging that they operate ghost networks.
Subsidiaries
Elevance Health includes the following subsidiaries:
Amerigroup
District of Columbia (Medicaid)
Georgia (Medicaid)
New Mexico (Medicare Advantage)
Anthem Blue Cross
California
Blue Cross of California Partnership Plan (Medicaid)
New York (upstate)
Anthem Blue Cross Blue Shield
Colorado
Connecticut
Georgia
Indiana (includes Medicaid)
Kentucky
Anthem Blue Cross and Blue Shield Medicaid
Maine
Missouri (excluding 30 counties in the Kansas City area)
Nevada
Anthem Blue Cross and Blue Shield Healthcare Solutions (Medicaid)
New Hampshire
New York (downstate)
HealthPlus (Medicaid)
Ohio
Virginia (excluding Alexandria City, Arlington County, Falls Church City, and parts of Fairfax County)
HealthKeepers (Medicaid)
Wisconsin
Carelon Behavioral Health
Carelon Behavioral Health of California
Carelon Behavioral Health of Kansas
Carelon Health of Pennsylvania
Carelon Global Solutions (Business Process Outsourcing/Shared Services)
Freedom Health
Florida
Golden West Dental & Vision
California
HealthSun
Florida
MMM
Puerto Rico
Optimum Healthcare
Florida
Simply Healthcare
Florida
UniCare
West Virginia
WellPoint
Arizona (Medicare Advantage)
Iowa (Medicaid and Medicare Advantage)
Maryland (Medicaid)
Massachusetts (government employees)
New Jersey (Medicaid and Medicare Advantage)
Tennessee (Medicaid and Medicare Advantage)
Texas (Medicaid and Medicare Advantage)
Washington (Medicaid and Medicare Advantage)
Joint ventures
Elevance Health operates joint ventures including:
Anthem | MaineHealth (with MaineHealth)
Maine
Blue Medicare Advantage (with Independence Blue Cross)
Pennsylvania
Colorado Community Health Alliance (with Centura Health, Physician Health Partners and Primary Physician Partners)
Colorado
Healthy Blue Kansas (with Blue Cross and Blue Shield of Kansas and Blue Cross and Blue Shield of Kansas City)
Kansas
Healthy Blue Louisiana (with Blue Cross Blue Shield of Louisiana)
Louisiana
Summit Community Care
Arkansas
Centers Plan for Healthy Living
New York, Florida
Quality of care
In 2011, in the category of "Meeting National Standards of Care," California's state patient advocacy office gave Anthem a rating of 2 out of 4 stars. In 2014, it received 3 out of 4 stars in the same category. In 2022, twenty-one of Elevance Health's affiliated Medicaid plans earned accreditation for health equity from the National Committee for Quality Assurance (NCQA).
Controversies
Charitable donations
In 2007, WellPoint pledged to spend $30 million over three years, through the company's charitable foundation, to help the uninsured. In March 2010, the Los Angeles Times reported that WellPoint's tax records and website showed that the company had given only $6.2 million by 2009. The company said that the foundation had indeed fulfilled its $30-million commitment by mid-2009, but refused to provide any financial details to support its claim.
2007 DMHC investigation
In 2007, the California Department of Managed Health Care (DMHC) investigated Anthem's policies for revoking (rescinding) health care insurance policies. The DMHC randomly selected 90 instances where Anthem canceled the insurance of policy holders who had been diagnosed with costly or life-threatening illnesses, to find how many of these cancellations were legal. The agency concluded that all these cancellations were illegal.
In July 2008, Anthem Blue Cross agreed to a settlement with the California Department of Managed Health Care; however in doing so, WellPoint did not officially admit liability. To resolve allegations of improper policy rescissions (cancellations), WellPoint paid $10 million and reinstated plans for 1,770 policy-holders who were affected by cancelled policies. The company also agreed to provide compensation for any medical debts incurred by these policy-holders.
2010 Reuters exposé
In April 2010, Reuters alleged that Wellpoint "using a computer algorithm, identified women recently diagnosed with breast cancer and then singled them out for cancellation of their policies." The software used immediately triggered fraud investigation for those recently diagnosed with the disease as the company searched for some pretext to drop their policies. Wellpoint argued that its algorithm was scanning for diagnostic codes for conditions that patients might have known about during the insurance application. The story not only caused considerable public outrage, but it also led Secretary of Health and Human Services, Kathleen Sebelius, and President Barack Obama, to call on WellPoint to end the practice.
In 2011, Anthem began cancelling policies of members who had been paying premiums with credit cards, sometimes without calling or emailing the member ahead of time.
Opposition to healthcare reform
In August 2009, Anthem, the largest for-profit insurer in California, contacted its employees and urged them to get involved to oppose healthcare reforms proposed during the Obama administration. Consumer Watchdog, a nonprofit watchdog organization in Santa Monica, asked California Attorney General Jerry Brown to investigate its claim that WellPoint had illegally pushed workers to write to their elected officials, attend town hall meetings and enlist family and friends to ensure an overhaul that would match the firm's interests. According to Consumer Watchdog, California's labor code directly prohibits coercive communications, including forbidding employers from controlling, coercing or influencing employees' political activities or affiliations. WellPoint had not been contacted by the California attorney general and had not seen any complaint.
Through 2010 and into 2011, WellPoint senior executives met monthly with executives of other major health insurers to blunt the effect of the Patient Protection and Affordable Care Act.
Premium increases in Maine
In 2009, Anthem Health Plans of Maine, a WellPoint subsidiary, sued the state of Maine for the right to increase premiums further. Since Maine licenses insurance companies through its Bureau of Insurance, Anthem needed the state's permission to raise rates. The Court disagreed with Anthem and found that, unlike with other forms of insurance, the Maine Insurance Code does not require the Superintendent to consider profits.
Rate increases in California
In February 2010, WellPoint announced that rates would increase on some Anthem Blue Cross individual policies in California by as high as 39%. The announcement resulted in an investigation by regulators from the Federal and California governments. Anthem Blue Cross gained worldwide media attention and became a poster child for the problem of rising cost of health care in the U.S. The rate increase came one year after Anthem had raised rates 68% on individual policy holders.
To explain the rate increases, some which were four times the rate of medical inflation, Anthem said the company had experienced a death spiral: the company claimed that with increased unemployment and declining wages, healthy customers dropped their insurance policies. Consequently, the remaining risk pool became sicker and thus more expensive to insure; and, in turn, prices were forced up and pushed more people out of the market.
In response to the outrage from politicians and consumers, Anthem postponed the rate increase until May 1, 2010.
Senator Dianne Feinstein of California proposed giving the Federal government of the United States authority to block insurance premium hikes that it considers to be "unjustified".
WellPoint cost reclassification
On March 17, 2010, WellPoint announced it was reclassifying some of its administrative costs as medical care costs in order to meet loss ratio requirements under the Patient Protection and Affordable Care Act, which requires insurers to spend at least 80% or 85% of customer premiums on health care services, depending on the type of plan.
2009–2010 data breach
In June 2010, Anthem sent letters to 230,000 customers in California warning them that their personal data might have been accessed online via a data breach. After a routine upgrade in October 2009, a third-party vendor stated that all security measures had been properly reinstated, when in fact they had not. As a result, personal information of thousands of coverage applicants who were under the age of 65 was exposed in the open. After a Los Angeles-area woman found that her application for coverage was publicly available, she filed a class action lawsuit against Anthem. While gathering evidence for the proceeding, the woman's lawyers downloaded some confidential customer information from Anthem's website and alerted Anthem about the breach. According to the lawyers, confidential information had remained exposed for five months. Greg Zoeller, Indiana's Attorney General, filed a lawsuit against the company seeking $300,000 in civil penalties for the company alleged failure to notify its consumers about the breach.
Denial of benefits for cancer treatment
In May 2014, Anthem Blue Cross refused to pay for the hospitalization of a Sonoma County, California man for stage four cancers, although he had paid Anthem over $100,000 in premiums. Anthem ended up paying for coverage following public outcry.
2015 data breach
On February 4, 2015, Anthem, Inc. disclosed that criminal hackers had broken into its servers and potentially stolen over 37.5 million records that contain personally identifiable information from its servers. According to Anthem, Inc., the data breach extended into multiple brands Anthem, Inc. uses to market its healthcare plans, including, Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross and Blue Shield, Amerigroup, Caremore, and UniCare. Healthlink was also victimized. Anthem says the medical information and financial data was not compromised. Anthem has offered free credit monitoring in the wake of the breach. According to Bloomberg News, China may be responsible for this data breach. Michael Daniel, chief adviser on cybersecurity for President Barack Obama, said he would be changing his own password. About 80 million company records were hacked, stoking fears that the stolen data could be used for identity theft. The compromised information contained names, birthdays, medical IDs, social security numbers, street addresses, e-mail addresses, employment information and income data. In June 2017, Anthem agreed to spend $115M to settle allegations that it failed to adequately protect the data of its clients, the sum was to be spent on two years of services to protect victims from identity theft. In 2019, two Chinese nationals were indicted for the breach.
"Avoidable ER program"
Beginning in 2015, Anthem has been implementing and expanding its "avoidable ER program" which means not reimbursing ER visits when the cause is not covered by the company. A few patients found out that they had been stuck with bills of over $10,000 that Anthem refused to reimburse. According to a 2013 report by the Journal of the American Medical Association, 87 percent of patients initially triaged as non-urgent ended up with a diagnosis that constituted an emergency. Critics derided the scheme, citing that it was unlawful by federal law to cover a person based on diagnosis, not symptoms. It was also considered unsafe, as it pressured patients to diagnose themselves before going to the ER.
Neglecting complaints
In 2017, the California Department of Managed Health Care fined the company $5 million for untimely response to consumer complaints. In 2019, this was settled at $2.8 million.
2019 lawsuit for coercive direct payments
In 2019, Sovereign Health pressed charges against Anthem, alleging that it was using direct payments to compel them to join Anthem's network under unfavorable terms. Sovereign owns facilities that treat people with addiction and mental health problems.
Diagnostics fraud
In March 2020, Anthem was sued by the Department of Justice. The lawsuit alleges that Anthem had submitted inaccurate diagnostics data in order to obtain increased Medicare reimbursements. In October 2022, a judge ordered Anthem to face the lawsuit.
Medicare Advantage star rating
In January 2024, Elevance Health filed a lawsuit with the Department of Health and Human Services (HHS) challenging changes in the Medicare Advantage star rating methodology. Star ratings are tied to key bonus payouts, and due to the new rating system in 2024 ratings have significantly decreased.
Finances
For the fiscal year 2017, Anthem reported earnings of US$3.843 billion, with an annual revenue of US$90.039 billion, an increase of 6.1% over the previous fiscal cycle. Anthem's shares traded at over $183 per share, and its market capitalization was valued at over US$69.1 billion in October 2018.
Recognition
The company was featured on the S&P Dow Jones Sustainability Index from 2018 to 2022, was named by Fortune as one of the 100 Best Companies to Work For, and was included on the Corporate Equality Index's list of Best Places to Work for LGBTQ Equality from 2015 to 2022.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
ELV Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
ELV Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
| Data ex | Valor |
|---|---|
| 10 de Junho de 2026 | $1,7200 |
| 10 de Março de 2026 | $1,7200 |
| 5 de Dezembro de 2025 | $1,7100 |
| 10 de Setembro de 2025 | $1,7100 |
| 10 de Junho de 2025 | $1,7100 |
| 10 de Março de 2025 | $1,7100 |
| 5 de Dezembro de 2024 | $1,6300 |
| 10 de Setembro de 2024 | $1,6300 |
| 10 de Junho de 2024 | $1,6300 |
| 7 de Março de 2024 | $1,6300 |
| 5 de Dezembro de 2023 | $1,4800 |
| 7 de Setembro de 2023 | $1,4800 |
| 8 de Junho de 2023 | $1,4800 |
| 9 de Março de 2023 | $1,4800 |
| 2 de Dezembro de 2022 | $1,2800 |
| 8 de Setembro de 2022 | $1,2800 |
| 9 de Junho de 2022 | $1,2800 |
| 9 de Março de 2022 | $1,2800 |
| 2 de Dezembro de 2021 | $1,1300 |
| 9 de Setembro de 2021 | $1,1300 |
ELV Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 7 24,1%
- Compra 12 41,4%
- Manter 10 34,5%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
21 analistas · 2026-08-20Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $7.45 | $6.27 | 1.2% |
| 31 de Março de 2026 | $12.58 | $10.93 | 1.6% |
| 31 de Dezembro de 2025 | $3.33 | $3.13 | 0.20% |
| 30 de Setembro de 2025 | $6.03 | $4.98 | 1.0% |
| 30 de Junho de 2025 | $8.84 | $9.04 | -0.20% |
| 31 de Março de 2025 | $11.97 | $11.50 | 0.47% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 13
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B | $121.87B | $104.21B | $92.11B | $90.04B | $84.86B | $79.16B | $73.87B | |
| Cost of Revenue | $21.18B | $19.75B | $17.29B | $13.04B | $10.89B | $8.95B | $1.99B | $0 | $0 | · | · | · | |
| SG&A Expense | $20.98B | $20.02B | $20.09B | $17.70B | $15.92B | $17.45B | $13.36B | $14.02B | $12.65B | $12.56B | $12.53B | $11.75B | |
| Operating Income | $7.20B | $7.86B | $8.50B | $8.28B | $7.56B | $6.36B | $6.00B | $5.43B | $4.17B | $4.80B | $4.75B | $4.42B | |
| Interest Expense | · | · | $1.03B | $851M | $798M | $784M | $746M | $753M | $739M | $723M | $653M | $601M | |
| Pretax Income | $6.71B | $7.90B | $7.71B | $7.60B | $8.00B | $6.24B | $5.99B | $5.07B | $3.96B | $4.55B | $4.63B | $4.37B | |
| Income Tax | $1.05B | $1.93B | $1.72B | $1.71B | $1.85B | $1.67B | $1.18B | $1.32B | $121M | $2.08B | $2.07B | $1.81B | |
| Net Income | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B | $4.81B | $3.75B | $3.84B | $2.47B | $2.56B | $2.57B | |
| EPS (Basic) | $25.28 | $25.81 | $25.38 | $24.56 | $25.26 | $18.23 | $18.81 | $14.53 | $14.70 | $9.39 | $9.73 | $9.31 | |
| EPS (Diluted) | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 | $17.98 | $18.47 | $14.19 | $14.35 | $9.21 | $9.38 | $8.99 | |
| Shares (Basic) | 224,000,000 | 231,700,000 | 235,900,000 | 240,000,000 | 243,800,000 | 250,800,000 | 255,500,000 | 258,100,000 | 261,500,000 | 262,900,000 | 263,000,000 | 275,900,000 | |
| Shares (Diluted) | 224,600,000 | 232,900,000 | 237,400,000 | 242,800,000 | 246,800,000 | 254,300,000 | 260,300,000 | 264,200,000 | 267,800,000 | 268,100,000 | 272,900,000 | 285,900,000 | |
| EBITDA | $8.74B | $9.26B | $10.24B | $10.13B | $8.79B | $7.51B | $6.00B | $5.43B | $4.18B | $4.80B | $4.75B | $4.42B |
Balanço Patrimonial 26
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.49B | $8.29B | $6.53B | $7.39B | $4.88B | $5.74B | $4.94B | $3.93B | $3.61B | $4.08B | $2.11B | $2.15B | |
| Other Current Assets | $5.34B | $4.70B | $5.79B | $5.28B | $4.65B | $4.06B | $3.02B | $2.10B | $2.25B | $1.78B | $1.56B | $1.47B | |
| Current Assets | $63.00B | $58.94B | $60.03B | $55.62B | $51.12B | $45.75B | $39.03B | $34.32B | $36.26B | $34.31B | $30.86B | $31.95B | |
| PP&E (Net) | $4.68B | $4.65B | $4.36B | $4.32B | $3.92B | $3.48B | $3.13B | $2.73B | $2.17B | $1.98B | $2.02B | $1.94B | |
| PP&E (Gross) | $8.73B | $8.33B | $7.90B | $7.12B | $8.26B | $7.33B | $6.48B | $5.55B | $4.37B | $4.14B | $4.06B | $3.76B | |
| Accum. Depreciation | $4.06B | $3.68B | $3.54B | $2.80B | $4.34B | $3.84B | $3.35B | $2.81B | $2.20B | $2.16B | $2.04B | $1.82B | |
| Goodwill | $28.34B | $28.28B | $25.32B | $24.38B | $24.23B | $21.69B | $20.50B | $20.50B | $19.23B | $17.56B | $17.56B | $17.08B | |
| Intangibles | $11.20B | $12.09B | $10.27B | $10.31B | $10.62B | $9.40B | $8.67B | $9.01B | $8.37B | $7.96B | $8.16B | $7.96B | |
| Other Non-current Assets | $2.31B | $2.14B | $1.97B | $1.69B | $1.72B | $1.44B | $1.35B | $758M | $565M | $468M | $485M | $512M | |
| Total Assets | $121.49B | $116.89B | $108.93B | $102.75B | $97.46B | $86.61B | $77.45B | $71.57B | $70.54B | $65.08B | $61.72B | $61.68B | |
| Accounts Payable | $7.32B | $6.93B | $6.91B | $5.61B | $4.97B | $5.49B | $4.20B | $4.96B | $5.02B | $4.01B | $3.32B | $3.65B | |
| Short-term Debt | $150M | $365M | $225M | $265M | $275M | $0 | $700M | $1.15B | $1.27B | $440M | $540M | $400M | |
| Current Liabilities | $41.03B | $40.58B | $41.79B | $39.70B | $34.88B | $29.45B | $23.53B | $21.96B | $23.36B | $21.29B | $19.09B | $18.75B | |
| Capital Leases | $529M | $658M | $685M | $751M | $864M | · | · | · | · | · | · | · | |
| Deferred Tax | $2.11B | $2.15B | $1.97B | $2.02B | $2.81B | $2.02B | $2.23B | $1.96B | $1.73B | $2.78B | $2.63B | $2.95B | |
| Other Non-current Liabilities | $3.53B | $3.33B | $1.74B | $1.56B | $1.68B | $1.81B | $1.42B | $1.18B | $925M | $884M | $994M | $1.04B | |
| Total Liabilities | $77.47B | $75.46B | $69.52B | $66.42B | $61.29B | $53.42B | $45.73B | $43.03B | $44.04B | $39.98B | $38.67B | $37.42B | |
| Long-term Debt | $31.90B | $30.87B | $24.89B | $23.85B | $22.76B | $20.04B | $19.39B | $18.07B | $18.66B | $15.29B | $15.32B | $14.64B | |
| Total Debt | $32.05B | $31.23B | $25.12B | $24.11B | $23.03B | $20.04B | $20.09B | $19.21B | $19.93B | $15.73B | $15.86B | $15.15B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Paid-in Capital | $8.94B | $8.91B | $8.87B | $9.08B | $9.15B | $9.24B | $9.45B | $9.54B | $8.55B | $8.81B | $8.56B | $10.06B | |
| Retained Earnings | $35.39B | $33.55B | $31.75B | $29.65B | $27.14B | $23.80B | $22.57B | $19.99B | $18.05B | $16.56B | $14.78B | $14.01B | |
| AOCI | $-451M | $-1.15B | $-1.31B | $-2.49B | $-197M | $150M | $-296M | $-986M | $-101M | $-268M | $-293M | $172M | |
| Stockholders' Equity | $43.88B | $41.31B | $39.31B | $36.24B | $36.09B | $33.20B | $31.73B | $28.54B | $26.50B | $25.10B | $23.05B | $24.25B | |
| Liabilities + Equity | $121.49B | $116.89B | $108.93B | $102.75B | $97.46B | $86.61B | $77.45B | $71.57B | $70.54B | $65.08B | $61.72B | $61.68B | |
| Shares Outstanding | 220,723,898 | 227,479,695 | 233,071,088 | 237,958,067 | 241,770,746 | 245,401,430 | 252,922,161 | 257,395,577 | 256,084,913 | 263,747,395 | 261,238,188 | 268,109,932 |
Fluxo de Caixa 18
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.55B | $1.39B | $1.75B | $1.68B | $1.30B | $1.15B | $1.13B | $1.13B | · | · | · | · | |
| Stock-based Comp | $276M | $191M | $289M | $264M | $255M | $283M | $294M | $226M | $170M | $165M | $148M | $169M | |
| Deferred Tax | $-279M | $-374M | $-602M | $-115M | $342M | $-540M | $81M | $91M | $-1.27B | $127M | $-66M | $31M | |
| Amort. of Intangibles | $628M | $580M | $885M | $767M | $441M | $361M | $338M | $358M | $169M | $192M | $230M | $221M | |
| Other Non-cash | $-2.92B | $-1.38B | $642M | $511M | $377M | $5.22B | · | · | · | · | · | · | |
| Operating Cash Flow | $4.29B | $5.81B | $8.06B | $8.40B | $8.36B | $10.69B | $6.06B | $3.83B | $4.18B | $3.27B | $4.21B | $3.37B | |
| CapEx | $1.12B | $1.26B | $1.30B | $1.15B | $1.09B | $1.02B | $1.08B | $1.21B | $791M | $584M | $638M | $715M | |
| Investing Cash Flow | $-1.34B | $-5.17B | $-5.57B | $-4.56B | $-9.64B | $-7.32B | $-2.79B | $-1.26B | $-5.08B | $-514M | $-1.15B | $-975M | |
| Debt Issued | $2.99B | $7.71B | $2.57B | $3.07B | $3.46B | $2.48B | $2.47B | $835M | $5.46B | $0 | $1.23B | $2.70B | |
| Net Debt Issued | $844M | $6.06B | $665M | $1.17B | $2.39B | $552M | $1.35B | $-849M | $2.64B | $0 | $-1.47B | $970M | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $1.25B | $0 | $0 | · | · | |
| Stock Repurchased | $2.60B | $2.90B | $2.68B | $2.32B | $1.90B | $2.70B | $1.70B | $1.69B | $2.00B | $0 | $1.52B | $3.00B | |
| Net Stock Activity | $-2.60B | $-2.90B | $-2.68B | $-2.32B | $-1.90B | $-2.70B | $-1.70B | $-435M | $-2.00B | $0 | $-1.52B | $-3.00B | |
| Dividends Paid | $1.53B | $1.51B | $1.40B | $1.23B | $1.10B | $954M | $818M | $776M | $705M | $684M | $657M | $481M | |
| Financing Cash Flow | $-1.74B | $1.19B | $-3.35B | $-1.32B | $423M | $-2.57B | $-2.27B | $-2.24B | $427M | $-799M | $-3.09B | $-1.82B | |
| Net Change in Cash | $1.20B | $1.83B | $-861M | $2.51B | $-861M | $804M | $1.00B | $325M | $-466M | $1.96B | $-38M | $565M | |
| Free Cash Flow | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B | $9.67B | $4.98B | $2.62B | $3.39B | $2.62B | $3.48B | $2.65B | |
| Levered FCF | · | · | $5.97B | $6.59B | $6.66B | $9.09B | $4.38B | $2.06B | $2.67B | $2.23B | $3.12B | $2.30B |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.6% | 4.4% | 5.0% | 5.4% | 5.4% | 5.2% | 5.8% | 5.9% | 4.6% | 5.7% | 6.0% | 6.0% | |
| Net Margin | 2.8% | 3.4% | 3.5% | 3.9% | 4.4% | 3.8% | 4.6% | 4.1% | 4.3% | 2.9% | 3.2% | 3.5% | |
| Pretax Margin | 3.4% | 4.5% | 4.5% | 5.0% | 5.7% | 5.1% | 5.7% | 5.5% | 4.4% | 5.4% | 5.9% | 5.9% | |
| EBITDA Margin | 4.4% | 5.2% | 6.0% | 6.5% | 6.3% | 6.2% | 5.8% | 5.9% | 4.6% | 5.7% | 6.0% | 6.0% | |
| ROA | 4.8% | 5.3% | 5.7% | 6.0% | 6.6% | 5.6% | 6.5% | 5.3% | 5.7% | 3.9% | 4.2% | 4.2% | |
| ROE | 13.3% | 14.8% | 15.8% | 16.7% | 17.0% | 13.6% | 15.2% | 13.0% | 14.6% | 9.9% | 11.1% | 10.6% | |
| ROIC | 8.0% | 8.2% | 10.2% | 10.8% | 9.8% | 8.8% | 9.3% | 8.4% | 8.7% | 6.4% | 6.8% | 6.6% |
Liquidez e Solvência 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | 1.4 | 1.4 | 1.5 | 1.6 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.7 | |
| Quick Ratio | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | |
| Debt / Equity | 0.7 | 0.8 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.6 | 0.7 | 0.6 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.6 | 0.7 | 0.6 | |
| Interest Coverage | · | · | 8.3 | 9.9 | 9.4 | 8.1 | 8.0 | 7.2 | 5.7 | 6.6 | 7.3 | 7.4 |
Eficiência 1
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.7 | 1.6 | 1.6 | 1.6 | 1.5 | 1.5 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 1.2 |
Taxas de Crescimento 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 12.5% | 3.3% | 9.4% | 13.0% | 13.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 8.3% | 8.5% | 12.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.8% | 1.8% | 3.9% | -2.7% | 38.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 1.3% | 0.97% | 11.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 7.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -5.3% | -0.12% | 1.6% | -4.3% | 34.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -1.3% | -0.97% | 9.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 9.9% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 17
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B | $121.87B | $104.21B | $92.11B | $90.04B | $84.86B | $79.16B | $73.87B | |
| Net Income TTM | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B | $4.81B | $3.75B | $3.84B | $2.47B | $2.56B | $2.57B | |
| Market Cap | $77.37B | $83.92B | $109.91B | $122.07B | $112.07B | $78.80B | $76.39B | $67.60B | $57.62B | $37.92B | $36.43B | $33.69B | |
| Enterprise Value | $99.93B | $106.86B | $128.50B | $138.79B | $130.22B | $93.09B | $91.54B | $82.88B | $73.94B | $49.57B | $50.18B | $46.69B | |
| P/E | 13.9 | 14.4 | 18.7 | 21.1 | 18.6 | 17.9 | 16.4 | 18.5 | 15.7 | 15.6 | 14.9 | 14.0 | |
| P/S | 0.4 | 0.5 | 0.6 | 0.8 | 0.8 | 0.6 | 0.7 | 0.7 | 0.6 | 0.4 | 0.5 | 0.5 | |
| P/B | 1.8 | 2.0 | 2.8 | 3.4 | 3.1 | 2.4 | 2.4 | 2.4 | 2.2 | 1.5 | 1.6 | 1.4 | |
| P / Tangible Book | 17.8 | 88.9 | 29.6 | 79.0 | 89.5 | 37.5 | · | · | · | · | · | · | |
| P / Cash Flow | 18.0 | 14.4 | 13.6 | 14.5 | 13.4 | 7.4 | 12.6 | 17.7 | 13.8 | 11.8 | 8.9 | 10.0 | |
| P / FCF | 24.4 | 18.4 | 16.2 | 16.8 | 15.4 | 8.2 | 15.3 | 25.8 | 17.0 | 14.5 | 10.5 | 12.7 | |
| EV / EBITDA | 11.4 | 11.5 | 12.5 | 13.7 | 14.8 | 12.4 | 15.3 | 15.3 | 17.7 | 10.3 | 10.6 | 10.6 | |
| EV / FCF | 31.5 | 23.5 | 19.0 | 19.2 | 17.9 | 9.6 | 18.4 | 31.6 | 21.8 | 18.9 | 14.4 | 17.6 | |
| EV / Revenue | 0.5 | 0.6 | 0.8 | 0.9 | 0.9 | 0.8 | 0.9 | 0.9 | 0.8 | 0.6 | 0.6 | 0.6 | |
| Dividend Yield | 2.0% | 1.8% | 1.3% | 1.0% | 0.99% | 1.2% | 1.1% | 1.1% | 1.2% | 1.8% | 1.8% | 1.4% | |
| Earnings Yield | 7.2% | 7.0% | 5.3% | 4.7% | 5.4% | 5.6% | 6.1% | 5.4% | 6.4% | 6.4% | 6.7% | 7.1% | |
| Payout Ratio | 27.0% | 25.2% | 23.3% | 20.4% | 18.1% | 20.9% | 17.0% | 20.7% | 18.3% | 27.7% | 25.7% | 18.7% | |
| Annual Payout | $1.53B | $1.51B | $1.40B | $1.23B | $1.10B | $954M | $818M | $776M | $705M | $684M | $657M | $481M |
Demonstração de Resultados 13
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $50.47B | $50.18B | $49.75B | $50.71B | $49.78B | $48.89B | $45.44B | $45.11B | $43.89B | $42.58B | $42.65B | $42.85B | $43.67B | $42.17B | $39.93B | $39.94B | |
| Cost of Revenue | $5.49B | $5.46B | $5.52B | $5.38B | $5.29B | $4.98B | $6.01B | $5.09B | $4.82B | $3.83B | $4.84B | $4.65B | $4.33B | $3.48B | $3.65B | $3.44B | |
| SG&A Expense | $5.55B | $6.33B | $5.42B | $5.27B | $5.00B | $5.30B | $4.80B | $5.27B | $5.07B | $4.89B | $5.00B | $5.47B | $4.82B | $4.80B | $4.57B | $4.52B | |
| Operating Income | $1.76B | $2.09B | $309M | $1.29B | $2.42B | $3.17B | $673M | $1.41B | $2.77B | $3.02B | $1.28B | $1.76B | $2.63B | $2.83B | $1.26B | $2.25B | |
| Interest Expense | · | · | · | · | · | · | · | $300M | $280M | $265M | · | $259M | $261M | $251M | · | $213M | |
| Pretax Income | $1.94B | $2.30B | $215M | $1.41B | $2.29B | $2.80B | $606M | $1.37B | $2.99B | $2.94B | $1.00B | $1.65B | $2.44B | $2.62B | $1.04B | $2.13B | |
| Income Tax | $483M | $544M | $-331M | $219M | $548M | $613M | $193M | $365M | $685M | $690M | $170M | $354M | $585M | $615M | $168M | $529M | |
| Net Income | $1.46B | $1.76B | $547M | $1.19B | $1.74B | $2.18B | $418M | $1.02B | $2.30B | $2.25B | $856M | $1.29B | $1.85B | $1.99B | $865M | $1.60B | |
| EPS (Basic) | $6.74 | $8.03 | $2.58 | $5.32 | $7.74 | $9.64 | $1.87 | $4.38 | $9.91 | $9.65 | $3.70 | $5.48 | $7.83 | $8.37 | $3.66 | $6.69 | |
| EPS (Diluted) | $6.71 | $8.00 | $2.56 | $5.32 | $7.72 | $9.61 | $1.88 | $4.36 | $9.85 | $9.59 | $3.68 | $5.45 | $7.79 | $8.30 | $3.61 | $6.62 | |
| Shares (Basic) | 217,000,000 | 219,800,000 | -450,900,000 | 223,300,000 | 225,200,000 | 226,400,000 | -465,100,000 | 231,900,000 | 232,200,000 | 232,700,000 | -473,500,000 | 235,300,000 | 236,600,000 | 237,500,000 | -481,700,000 | 239,600,000 | |
| Shares (Diluted) | 217,900,000 | 220,400,000 | -452,100,000 | 223,700,000 | 225,800,000 | 227,200,000 | -467,800,000 | 233,100,000 | 233,400,000 | 234,200,000 | -476,600,000 | 236,500,000 | 237,800,000 | 239,700,000 | -487,200,000 | 242,200,000 | |
| EBITDA | $1.76B | $2.44B | · | $1.29B | $2.42B | $3.54B | · | $1.64B | $2.77B | $3.35B | · | $1.76B | $2.63B | $3.29B | · | $2.27B |
Balanço Patrimonial 26
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.23B | $9.66B | $9.49B | $8.71B | $8.56B | $7.50B | $8.29B | $7.87B | $6.50B | $6.23B | · | $10.92B | $9.99B | $10.14B | · | $8.87B | |
| Other Current Assets | $6.28B | $7.17B | $5.34B | $5.21B | $5.41B | $5.29B | $4.70B | $5.95B | $6.46B | $6.39B | · | $5.36B | $4.94B | $4.94B | · | $5.50B | |
| Current Assets | $67.18B | $67.03B | $63.00B | $63.78B | $63.32B | $61.12B | $58.94B | $62.85B | $62.27B | $60.95B | · | $61.19B | $59.74B | $59.82B | · | $55.60B | |
| PP&E (Net) | $4.64B | $4.66B | $4.68B | $4.66B | $4.64B | $4.62B | $4.65B | $4.50B | $4.45B | $4.45B | · | $4.25B | $4.55B | $4.42B | · | $4.20B | |
| PP&E (Gross) | · | · | $8.73B | · | · | · | $8.33B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $4.06B | · | · | · | $3.68B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $28.34B | $28.34B | $28.34B | $28.45B | $28.37B | $28.42B | $28.28B | $25.97B | $25.96B | $25.95B | $25.32B | $25.29B | $25.27B | $25.27B | $24.38B | $24.38B | |
| Intangibles | $10.98B | $11.09B | $11.20B | $11.33B | $11.49B | $11.94B | $12.09B | $10.32B | $10.45B | $10.71B | · | $10.49B | $10.70B | $10.91B | · | $10.54B | |
| Other Non-current Assets | $2.90B | $2.58B | $2.31B | $2.78B | $2.56B | $2.39B | $2.14B | $2.60B | $2.20B | $2.25B | · | $2.33B | $2.13B | $1.86B | · | $2.17B | |
| Total Assets | $126.44B | $125.83B | $121.49B | $122.75B | $121.94B | $119.72B | $116.89B | $116.53B | $112.99B | $111.89B | · | $110.48B | $109.17B | $109.04B | · | $103.03B | |
| Accounts Payable | $6.63B | $6.21B | $7.32B | $6.08B | $7.28B | $7.13B | $6.93B | $6.25B | $5.76B | $5.66B | · | $5.98B | $5.03B | $4.87B | · | $4.96B | |
| Short-term Debt | $0 | $724M | $150M | $180M | $360M | $250M | $365M | $360M | $225M | $1.57B | · | $0 | $265M | $265M | · | $265M | |
| Current Liabilities | $44.25B | $45.31B | $41.03B | $40.88B | $43.83B | $42.70B | $40.58B | $42.03B | $41.81B | $44.33B | · | $43.34B | $41.57B | $41.89B | · | $41.29B | |
| Capital Leases | · | · | $529M | · | · | · | $658M | · | · | · | · | $695M | $717M | $727M | · | $739M | |
| Deferred Tax | $2.21B | $1.79B | $2.11B | $2.31B | $2.01B | $2.12B | $2.15B | $2.09B | $2.04B | $2.20B | · | $1.78B | $1.85B | $2.03B | · | $1.82B | |
| Other Non-current Liabilities | $4.29B | $3.92B | $3.38B | $4.14B | $3.90B | $3.99B | $3.33B | $3.59B | $1.99B | $1.91B | · | $1.97B | $1.78B | $1.65B | · | $1.79B | |
| Total Liabilities | $81.42B | $81.78B | $77.47B | $78.67B | $78.09B | $77.10B | $75.46B | $72.65B | $70.69B | $71.18B | · | $71.94B | $70.86B | $71.58B | · | $66.98B | |
| Long-term Debt | $31.04B | $31.12B | $31.90B | $31.92B | $29.83B | $29.75B | $30.87B | $26.79B | $27.46B | $24.88B | · | $24.84B | $24.86B | $25.20B | · | $23.51B | |
| Total Debt | $31.04B | $31.84B | · | $32.10B | $30.19B | $30.00B | · | $27.15B | $27.69B | $26.45B | · | $24.84B | $25.12B | $25.47B | · | $23.77B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Paid-in Capital | $8.92B | $8.85B | $8.94B | $8.91B | $8.93B | $8.87B | $8.91B | $9.11B | $9.00B | $8.88B | · | $8.83B | $8.76B | $8.70B | · | $9.17B | |
| Retained Earnings | $36.67B | $35.80B | $35.39B | $35.59B | $35.55B | $34.55B | $33.55B | $35.16B | $34.58B | $33.09B | · | $32.10B | $31.61B | $30.71B | · | $29.60B | |
| AOCI | $-711M | $-741M | $-451M | $-543M | $-760M | $-911M | $-1.15B | $-489M | $-1.39B | $-1.36B | · | $-2.51B | $-2.17B | $-2.05B | · | $-2.78B | |
| Stockholders' Equity | $44.88B | $43.90B | $43.88B | $43.95B | $43.72B | $42.50B | $41.31B | $43.77B | $42.19B | $40.61B | · | $38.42B | $38.20B | $37.36B | · | $35.99B | |
| Liabilities + Equity | $126.44B | $125.83B | $121.49B | $122.75B | $121.94B | $119.72B | $116.89B | $116.53B | $112.99B | $111.89B | · | $110.48B | $109.17B | $109.04B | · | $103.03B | |
| Shares Outstanding | 216,841,146 | 217,368,494 | 220,723,898 | 222,036,187 | 224,835,508 | 225,641,361 | 227,479,695 | 231,929,643 | 231,902,075 | 232,544,717 | · | 234,906,987 | 235,861,650 | 237,114,190 | · | 238,974,624 |
Fluxo de Caixa 17
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $366M | $354M | $406M | $387M | $380M | $373M | $831M | $231M | $0 | $331M | $1.06B | $220M | $0 | $462M | $473M | $451M | |
| Stock-based Comp | $75M | $55M | $30M | $84M | $81M | $81M | $-29M | $66M | $92M | $62M | $72M | $78M | $78M | $61M | $73M | $69M | |
| Deferred Tax | $151M | $-274M | $-322M | $269M | $-52M | $-174M | $-116M | $-224M | $-170M | $136M | $-241M | $32M | $-138M | $-255M | $68M | $-11M | |
| Amort. of Intangibles | $110M | $112M | $164M | $162M | $147M | $155M | $180M | $122M | $162M | $116M | $217M | $212M | $221M | $235M | $247M | $225M | |
| Other Non-cash | · | $2.43B | · | · | · | $-1.45B | · | · | · | $-797M | · | · | · | $4.21B | · | · | |
| Operating Cash Flow | $1.91B | $4.33B | $84M | $1.14B | $2.05B | $1.02B | $706M | $2.68B | $447M | $1.98B | $-2.97B | $2.61B | $1.95B | $6.47B | $-1.52B | $4.92B | |
| CapEx | $287M | $235M | $293M | $360M | $267M | $196M | $322M | $332M | $323M | $279M | $326M | $319M | $350M | $301M | $298M | $305M | |
| Investing Cash Flow | $159M | $-1.64B | $464M | $-1.22B | $-687M | $103M | $-1.64B | $-401M | $-818M | $-2.31B | $-1.03B | $-687M | $-672M | $-3.18B | $289M | $-1.25B | |
| Debt Issued | · | · | $-3M | $2.99B | · | · | $5.13B | $0 | $2.58B | $0 | $0 | $0 | $0 | $2.57B | $1.78B | $-14M | |
| Net Debt Issued | · | $-750M | · | · | · | $-1.25B | · | · | · | $0 | · | · | · | $666M | · | · | |
| Stock Repurchased | $234M | $1.12B | $471M | $876M | $378M | $880M | $1.81B | $60M | $463M | $566M | $928M | $480M | $646M | $622M | $568M | $579M | |
| Net Stock Activity | · | $-1.12B | · | · | · | $-880M | · | · | · | $-566M | · | · | · | $-622M | · | · | |
| Dividends Paid | $373M | $376M | $377M | $376M | $385M | $386M | $373M | $386M | $378M | $379M | $346M | $348M | $350M | $351M | $305M | $306M | |
| Financing Cash Flow | $-1.49B | $-2.52B | $236M | $243M | $-308M | $-1.91B | $1.41B | $-915M | $668M | $32M | $-394M | $-994M | $-1.43B | $-531M | $-258M | $-1.25B | |
| Net Change in Cash | $575M | $166M | $778M | $153M | $1.06B | $-788M | $468M | $1.37B | $292M | $-300M | $-4.39B | $928M | $-151M | $2.75B | $-1.49B | $2.42B | |
| Free Cash Flow | · | $4.10B | · | · | · | $821M | · | · | · | $1.70B | · | · | · | $6.17B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.50B | · | · | · | $5.98B | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.5% | 4.2% | · | 2.5% | 4.9% | 6.5% | · | 3.1% | 6.3% | 7.1% | · | 4.1% | 6.0% | 6.7% | · | 5.7% | |
| Net Margin | 2.9% | 3.5% | · | 2.3% | 3.5% | 4.5% | · | 2.2% | 5.2% | 5.3% | · | 3.0% | 4.2% | 4.7% | · | 4.0% | |
| Pretax Margin | 3.8% | 4.6% | · | 2.8% | 4.6% | 5.7% | · | 3.0% | 6.8% | 6.9% | · | 3.9% | 5.6% | 6.2% | · | 5.4% | |
| EBITDA Margin | 3.5% | 4.9% | · | 2.5% | 4.9% | 7.2% | · | 3.6% | 6.3% | 7.9% | · | 4.1% | 6.0% | 7.8% | · | 5.7% | |
| ROA | 1.2% | 1.4% | · | 0.99% | 1.5% | 1.9% | · | 0.90% | 2.1% | 2.0% | · | 1.2% | 1.8% | 1.9% | · | 1.6% | |
| ROE | 3.3% | 4.1% | · | 2.7% | 4.1% | 5.2% | · | 2.5% | 5.7% | 5.8% | · | 3.5% | 5.0% | 5.4% | · | 4.5% | |
| ROIC | 1.7% | 2.1% | · | 1.4% | 2.5% | 3.4% | · | 1.5% | 3.0% | 3.4% | · | 2.2% | 3.2% | 3.5% | · | 2.9% |
Liquidez e Solvência 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | · | 1.6 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | |
| Interest Coverage | · | · | · | · | · | · | · | 4.7 | 9.9 | 11.4 | · | 6.8 | 10.1 | 11.3 | · | 10.7 |
Eficiência 1
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 |
Avaliação (TTM) 17
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $201.14B | $199.56B | · | $194.48B | $187.66B | $180.46B | · | $174.42B | $172.98B | $171.27B | · | $168.63B | $164.41B | $158.84B | · | $152.49B | |
| Net Income TTM | $6.16B | $6.88B | · | $6.13B | $7.24B | $7.75B | · | $6.85B | $7.69B | $7.38B | · | $6.73B | $7.08B | $7.02B | · | $6.54B | |
| Market Cap | $83.86B | $63.63B | · | $71.74B | $87.45B | $98.14B | · | $120.60B | $125.66B | $120.58B | · | $102.28B | $104.79B | $109.03B | · | $108.55B | |
| Enterprise Value | $104.67B | $85.82B | · | $95.13B | $109.08B | $120.65B | · | $139.89B | $146.85B | $140.81B | · | $116.21B | $119.92B | $124.35B | · | $123.45B | |
| P/E | 13.9 | 9.6 | · | 12.0 | 12.3 | 13.0 | · | 17.8 | 16.6 | 16.7 | · | 15.5 | 15.1 | 15.9 | · | 16.9 | |
| P/S | 0.4 | 0.3 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| P/B | 1.9 | 1.4 | · | 1.6 | 2.0 | 2.3 | · | 2.8 | 3.0 | 3.0 | · | 2.7 | 2.7 | 2.9 | · | 3.0 | |
| P / Tangible Book | 15.1 | 14.2 | · | 17.2 | 22.6 | 45.8 | · | 16.1 | 21.7 | 30.5 | · | 38.7 | 47.0 | 93.3 | · | 101.1 | |
| P / Cash Flow | · | 14.7 | · | · | · | 96.5 | · | · | · | 61.0 | · | · | · | 16.9 | · | · | |
| P / FCF | · | 15.5 | · | · | · | 119.5 | · | · | · | 71.0 | · | · | · | 17.7 | · | · | |
| EV / EBITDA | 59.4 | 35.2 | · | 73.5 | 45.0 | 34.1 | · | 85.3 | 53.1 | 42.1 | · | 66.2 | 45.6 | 37.8 | · | 54.4 | |
| EV / FCF | · | 20.9 | · | · | · | 147.0 | · | · | · | 82.9 | · | · | · | 20.2 | · | · | |
| EV / Revenue | 0.5 | 0.4 | · | 0.5 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | |
| Dividend Yield | 1.8% | 2.4% | · | 2.1% | 1.8% | 1.6% | · | 1.2% | 1.1% | 1.2% | · | 1.3% | 1.2% | 1.2% | · | 1.1% | |
| Earnings Yield | 7.2% | 10.5% | · | 8.4% | 8.1% | 7.7% | · | 5.6% | 6.0% | 6.0% | · | 6.5% | 6.6% | 6.3% | · | 5.9% | |
| Payout Ratio | 25.5% | 21.3% | · | 32.0% | 22.1% | 17.7% | · | 37.2% | 16.4% | 16.9% | · | 27.0% | 18.9% | 17.6% | · | 18.9% | |
| Annual Payout | $1.50B | $1.51B | · | $1.52B | $1.53B | $1.52B | · | $1.49B | $1.45B | $1.42B | · | $1.35B | $1.31B | $1.27B | · | $1.20B |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B |
| Margem Operacional % | 3.6% | 4.4% | 5.0% | 5.4% | 5.4% |
| Lucro líquido | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B |
| EPS Diluído | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.7 | 0.8 | 0.6 | 0.7 | 0.6 |
| Índice de liquidez corrente | 1.5 | 1.5 | 1.4 | 1.4 | 1.5 |
| Índice de Liquidez Seca | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B |
Últimas notícias Notícias recentes mencionando esta empresa
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 1.772 declarantes · $54.8B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 264 (+95 vs trimestre anterior) | 94 (-108 vs trimestre anterior) | 589 (+108 vs trimestre anterior) | 541 (-102 vs trimestre anterior) | +7.9M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $7.274.315.633 | 20.751.150 | 13,26% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.436.729.233 | 14.058.204 | 9,91% | Ações |
| STATE STREET CORP | $4.032.282.885 | 10.426.610 | 7,35% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $3.179.014.962 | 8.220.244 | 5,80% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.403.277.896 | 6.214.356 | 4,38% | Ações |
| Sanders Capital, LLC | $2.252.711.532 | 5.825.024 | 4,11% | Ações |
| Artisan Partners Limited Partnership | $1.771.695.984 | 4.581.222 | 3,23% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $1.712.764.692 | 4.448.634 | 3,12% | Ações |
| NORGES BANK | $1.531.008.381 | 3.958.856 | 2,79% | Ações |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $779.725.026 | 2.016.200 | 1,42% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $697.513.963 | 1.803.620 | 1,27% | Ações |
| Grantham, Mayo, Van Otterloo & Co. LLC | $654.221.093 | 1.691.671 | 1,19% | Ações |
| FMR LLC | $633.317.160 | 1.637.621 | 1,15% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $591.084.393 | 1.528.416 | 1,08% | Ações |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $588.871.451 | 1.522.694 | 1,07% | Ações |
| EAGLE CAPITAL MANAGEMENT LLC | $576.772.638 | 1.491.409 | 1,05% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $511.706.827 | 1.323.163 | 0,93% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $511.575.693 | 1.322.824 | 0,93% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $461.498.831 | 1.193.336 | 0,84% | Ações |
| Ruane, Cunniff & Goldfarb L.P. | $378.839.935 | 979.598 | 0,69% | Ações |
| Brave Warrior Advisors, LLC | $377.790.736 | 976.885 | 0,69% | Ações |
| Newport Trust Company, LLC | $369.294.278 | 954.915 | 0,67% | Ações |
| 1832 Asset Management L.P. | $355.109.795 | 918.237 | 0,65% | Ações |
| CITADEL ADVISORS LLC | $293.751.600 | 759.578 | 0,54% | Ações |
| Capital International Investors | $290.732.899 | 751.772 | 0,53% | Ações |
| MILLENNIUM MANAGEMENT LLC | $281.369.666 | 727.561 | 0,51% | Ações |
| BlackRock, Inc. | $268.353.881 | 693.905 | 0,49% | Ações |
| High Ground Investment Management LLP | $262.939.273 | 679.904 | 0,48% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $261.530.030 | 676.260 | 0,48% | Ações |
| Legal & General Group Plc | $259.012.033 | 669.749 | 0,47% | Ações |
| ACR Alpine Capital Research, LLC | $254.804.222 | 658.869 | 0,46% | Ações |
| Qube Research & Technologies Ltd | $247.577.198 | 640.181 | 0,45% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $240.259.106 | 621.258 | 0,44% | Ações |
| Swiss National Bank | $239.610.173 | 619.580 | 0,44% | Ações |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $237.525.699 | 614.190 | 0,43% | Ações |
| National Pension Service | $228.059.708 | 589.713 | 0,42% | Ações |
| GOLDMAN SACHS GROUP INC | $222.913.559 | 576.406 | 0,41% | Ações |
| Sumitomo Mitsui Trust Group, Inc. | $220.953.931 | 571.339 | 0,40% | Ações |
| Mitsubishi UFJ Asset Management Co., Ltd. | $205.911.600 | 532.437 | 0,38% | Ações |
| Ninety One UK Ltd | $196.567.097 | 508.280 | 0,36% | Ações |
| ALLIANCEBERNSTEIN L.P. | $191.531.395 | 654.249 | 0,35% | Ações |
| FIRST TRUST ADVISORS LP | $189.503.803 | 490.016 | 0,35% | Ações |
| Vanguard Global Advisers, LLC | $183.654.210 | 474.890 | 0,33% | Ações |
| ENVESTNET ASSET MANAGEMENT INC | $181.045.755 | 468.145 | 0,33% | Ações |
| 8 KNOTS MANAGEMENT, LLC | $179.336.122 | 511.585 | 0,33% | Ações |
| Focused Investors LLC | $178.514.568 | 461.600 | 0,33% | Ações |
| Nuveen Asset Management, LLC | $171.198.670 | 464.079 | 0,31% | Ações |
| DAVENPORT & Co LLC | $171.104.235 | 441.940 | 0,31% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $167.143.159 | 432.196 | 0,30% | Ações |
| Veritas Asset Management LLP | $165.780.323 | 428.672 | 0,30% | Ações |
| RHUMBLINE ADVISERS | $161.791.876 | 418.359 | 0,29% | Ações |
| California Public Employees Retirement System | $157.606.784 | 407.537 | 0,29% | Ações |
| FIL Ltd | $157.293.146 | 406.726 | 0,29% | Ações |
| MANNING & NAPIER ADVISORS LLC | $142.522.435 | 367.297 | 0,26% | Ações |
| Canoe Financial LP | $140.577.902 | 363.504 | 0,26% | Ações |
| YACKTMAN ASSET MANAGEMENT LP | $131.482.399 | 339.985 | 0,24% | Ações |
| BANK OF AMERICA CORP /DE/ | $121.697.356 | 314.683 | 0,22% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $121.433.220 | 314.000 | 0,22% | Opção de venda |
| AMERIPRISE FINANCIAL INC | $119.565.700 | 309.171 | 0,22% | Ações |
| Swedbank AB | $116.986.211 | 302.501 | 0,21% | Ações |
| Assenagon Asset Management S.A. | $115.776.907 | 299.374 | 0,21% | Ações |
| M&G PLC | $114.210.666 | 295.118 | 0,21% | Ações |
| Quantinno Capital Management LP | $112.935.724 | 292.027 | 0,21% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $112.933.654 | 282.040 | 0,21% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $107.897.670 | 279.000 | 0,20% | Opção de compra |
| BANK OF NOVA SCOTIA | $101.450.881 | 262.330 | 0,18% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $96.843.749 | 330.807 | 0,18% | Ações |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $96.574.989 | 249.722 | 0,18% | Ações |
| Caisse de depot et placement du Quebec | $94.418.969 | 244.147 | 0,17% | Ações |
| Sound Shore Management Inc /CT/ | $94.150.192 | 243.452 | 0,17% | Ações |
| NEW YORK STATE COMMON RETIREMENT FUND | $93.705.452 | 242.302 | 0,17% | Ações |
| AMF Tjanstepension AB | $92.093.175 | 238.133 | 0,17% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $91.136.405 | 235.659 | 0,17% | Ações |
| MACKENZIE FINANCIAL CORP | $90.587.635 | 234.240 | 0,17% | Ações |
| ROYAL LONDON ASSET MANAGEMENT LTD | $89.603.021 | 231.694 | 0,16% | Ações |
| JANE STREET GROUP, LLC | $87.130.269 | 225.300 | 0,16% | Opção de compra |
| PZENA INVESTMENT MANAGEMENT LLC | $86.849.890 | 224.575 | 0,16% | Ações |
| Marathon Asset Management Ltd | $84.882.114 | 219.490 | 0,15% | Ações |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $84.674.534 | 218.950 | 0,15% | Ações |
| BARCLAYS PLC | $79.161.697 | 204.695 | 0,14% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $77.876.980 | 201.373 | 0,14% | Ações |
| CITADEL ADVISORS LLC | $77.152.635 | 199.500 | 0,14% | Opção de venda |
| AVIVA PLC | $77.089.211 | 199.336 | 0,14% | Ações |
| TD Asset Management Inc | $75.328.430 | 194.783 | 0,14% | Ações |
| Maple Rock Capital Partners Inc. | $74.058.795 | 191.500 | 0,14% | Ações |
| Mawer Investment Management Ltd. | $72.431.822 | 187.293 | 0,13% | Ações |
| Freestone Grove Partners LP | $72.096.914 | 186.427 | 0,13% | Ações |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $71.577.149 | 185.083 | 0,13% | Ações |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $71.371.408 | 184.551 | 0,13% | Ações |
| Orbis Allan Gray Ltd | $70.845.455 | 183.191 | 0,13% | Ações |
| Jefferies Financial Group Inc. | $69.850.785 | 180.619 | 0,13% | Ações |
| CITADEL ADVISORS LLC | $69.069.978 | 178.600 | 0,13% | Opção de compra |
| Korea Investment CORP | $68.952.025 | 178.295 | 0,13% | Ações |
| Harvest Portfolios Group Inc. | $68.795.400 | 177.890 | 0,13% | Ações |
| RAYMOND JAMES FINANCIAL INC | $68.556.341 | 177.272 | 0,12% | Ações |
| LPL Financial LLC | $67.831.262 | 175.397 | 0,12% | Ações |
| Alyeska Investment Group, L.P. | $67.228.756 | 173.839 | 0,12% | Ações |
| Robeco Institutional Asset Management B.V. | $66.324.193 | 171.500 | 0,12% | Ações |
| APG Asset Management N.V. | $66.031.619 | 195.211 | 0,12% | Ações |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $66.009.784 | 170.687 | 0,12% | Ações |
Executivos da empresa 93 insiders · 55 diretores · 37 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Gail Boudreaux | President and CEO | 17 de Julho de 2026 P | 171.976 | 2 | 0 | $1.002.230 |
| Brian T Griffin | EVP & CEO, IngenioRx | 3 de Maio de 2018 M | 15.863 | 0 | 0 | $0 |
| Angela F Braly | Chair, President & CEO | 1 de Março de 2012 A | 476.503 | 0 | 0 | $0 |
| Brian A Sassi | President & CEO Cons, EVP | 7 de Junho de 2011 S | 60.825 | 0 | 0 | $0 |
| Dijuana K Lewis | Pres & CEO CHS and EVP | 20 de Maio de 2010 M | 44.107 | 0 | 0 | $0 |
| Mark L Boxer | Pres & CEO of OT&GS and EVP | 4 de Abril de 2008 F | 42.143 | 0 | 0 | $0 |
| Joan E Herman | President & CEO Cons and EVP | 7 de Dezembro de 2007 S | 30.369 | 0 | 0 | $0 |
| Mark Kaye | EVP & CFO | 24 de Abril de 2025 S | 18.977 | 0 | 0 | $0 |
| John E Gallina | EVP & Chief Financial Officer | 1 de Março de 2023 A | 63.725 | 0 | 0 | $0 |
| Wayne S Deveydt | EVP & Chief Financial Officer | 3 de Março de 2016 F | 57.957 | 0 | 0 | $0 |
| David C Colby | Vice Chairman, CFO & EVP | 4 de Abril de 2007 F | 343.071 | 0 | 0 | $0 |
| Thomas R Byrd | President, Anthem Specialty | 26 de Novembro de 2004 A | 26.580 | 0 | 0 | $0 |
| Michael D Houk | President, National Accounts | 4 de Novembro de 2004 M | 18.843 | 0 | 0 | $0 |
| John M Murphy | President, Specialty Business | 17 de Maio de 2004 A | 20.806 | 0 | 0 | $0 |
| Caroline S Matthews | Chief Operating Officer | 1 de Dezembro de 2004 A | 40.471 | 0 | 0 | $0 |
| Ronald W Penczek | CAO & Controller | 12 de Junho de 2026 S | 3.740 | 0 | 1 | $-148.766 |
| Charles Morgan Kendrick JR | EVP & President, Commercial | 3 de Março de 2025 A | 10.116 | 0 | 0 | $0 |
| Felicia F Norwood | EVP & President,Gov Health Ben | 3 de Março de 2025 A | 31.939 | 0 | 0 | $0 |
| Ratnakar Lavu | EVP, Chief Digital & Info Off | 3 de Março de 2025 A | 4.783 | 0 | 0 | $0 |
| Peter D Haytaian | EVP & Pres Carelon & CarelonRx | 3 de Março de 2025 A | 26.004 | 0 | 0 | $0 |
| Blair Williams Todt | EVP, CLO & CAO | 3 de Janeiro de 2025 F | 15.631 | 0 | 0 | $0 |
| Gloria M Mccarthy | EVP & Chief Administrative Off | 24 de Março de 2023 S | 51.435 | 0 | 0 | $0 |
| Leah Stark | EVP & CHRO | 30 de Dezembro de 2021 F | 12.403 | 0 | 0 | $0 |
| Jeffrey D. Alter | EVP, IngenioRx & Anthem Health | 1 de Outubro de 2021 F | 5.107 | 0 | 0 | $0 |
| Patel Prakash R | EVP & President, DBG | 4 de Setembro de 2021 F | 17.230 | 0 | 0 | $0 |
| Thomas C Zielinski | EVP & General Counsel | 3 de Novembro de 2020 M | 17.910 | 0 | 0 | $0 |
| Craig E Samitt | EVP & President, DBG | 26 de Julho de 2018 M | 17.274 | 0 | 0 | $0 |
| Joseph Swedish | Executive Chairman | 5 de Março de 2018 S | 61.419 | 0 | 0 | $0 |
| Jacquelyn H Wolf | EVP & Chief HR Officer | 1 de Março de 2018 A | 3.105 | 0 | 0 | $0 |
| Jose D. Tomas | EVP & Chief HR Officer | 3 de Março de 2017 F | 23.927 | 0 | 0 | $0 |
| Samuel R Nussbaum MD | EVP & Chief Medical Officer | 19 de Maio de 2015 M | 110.973 | 0 | 0 | $0 |
| Martin B Silverstein | EVP & Chief Strategy Officer | 1 de Maio de 2015 F | 23.249 | 0 | 0 | $0 |
| Kenneth R Goulet | EVP, Commercial & Specialty | 2 de Março de 2015 A | 84.281 | 0 | 0 | $0 |
| Richard C Zoretic | EVP, Gov Business Division | 3 de Março de 2014 A | 53.572 | 0 | 0 | $0 |
| John Cannon | EVP, GC & Chief PAO | 13 de Dezembro de 2013 S | 99.331 | 0 | 0 | $0 |
| Randal L Brown | EVP & Chief HR Officer | 4 de Setembro de 2013 M | 30.332 | 0 | 0 | $0 |
| Lori A Beer | EVP, Specialty Businesses & IT | 30 de Maio de 2013 M | 113.955 | 0 | 0 | $0 |
| Harlan A Levine | EVP, CHS | 31 de Agosto de 2012 S | 25.244 | 0 | 0 | $0 |
| Venkata R Madabhushi | EVP Sr Bus & Chf Transfrmn Off | 2 de Abril de 2012 A | 45.237 | 0 | 0 | $0 |
| Miller Martin | SVP & Chief Accounting Officer | 1 de Março de 2011 A | 29.329 | 0 | 0 | $0 |
| Fluegel M Bradley | EVP, Chief Strategy Officer | 5 de Novembro de 2010 M | 52.634 | 0 | 0 | $0 |
| Cynthia S Miller | EVP & Chief Actuary | 1 de Março de 2010 A | 60.757 | 0 | 0 | $0 |
| Randall J Lewis | EVP & Chief Compliance Officer | 7 de Agosto de 2009 M | 13.658 | 0 | 0 | $0 |
| Jamie S Miller | SVP & Chief Accounting Officer | 3 de Março de 2008 A | 25.710 | 0 | 0 | $0 |
| Alice F Rosenblatt | EVP and Chief Actuary | 22 de Janeiro de 2008 S | 39.265 | 0 | 0 | $0 |
| John S Watts JR | EVP | 7 de Dezembro de 2007 S | 108.311 | 0 | 0 | $0 |
| Marjorie W Dorr | EVP | 22 de Maio de 2007 M | 38.951 | 0 | 0 | $0 |
| Michael A Stocker | EVP | 23 de Outubro de 2006 M | 42.186 | 0 | 0 | $0 |
| Keith R Faller | EVP | 12 de Setembro de 2006 M | 83.290 | 0 | 0 | $0 |
| David S Helwig | EVP | 18 de Agosto de 2006 M | 55.055 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 220 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IHF · iShares Trust | 7,20% | 221.824 SH | 21 de Agosto de 2026 | Diário |
| GFGF · EA Series Trust | 3,75% | 3.541 NS | 29 de Maio de 2026 | N-PORT |
| MDPL · Northern Lights Fund Trust IV | 3,24% | 5.013 NS | 31 de Maio de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,78% | 64.637 NS | 30 de Abril de 2026 | N-PORT |
| ABCS · EA Series Trust | 2,29% | 661 NS | 29 de Maio de 2026 | N-PORT |
| FEGE · RBB Fund Trust | 1,92% | 94.302 NS | 31 de Maio de 2026 | N-PORT |
| QLTY · GMO ETF Trust | 1,75% | 200.065 NS | 31 de Maio de 2026 | N-PORT |
| TOLL · Tema ETF Trust | 1,71% | 2.139 NS | 31 de Maio de 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,54% | 7.891 NS | 30 de Abril de 2026 | N-PORT |
| BKDV · BNY Mellon ETF Trust II | 1,52% | 55.921 NS | 30 de Abril de 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 1,51% | 66.138 SH | 21 de Agosto de 2026 | Diário |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,41% | 29.279 SH | 21 de Agosto de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 1,35% | 102.444 NS | 30 de Abril de 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,33% | 62.208 SH | 21 de Agosto de 2026 | Diário |
| IYH · iShares Trust | 1,33% | 129.500 SH | 21 de Agosto de 2026 | Diário |
| RXL · ProShares Trust | 1,26% | 2.301 NS | 31 de Maio de 2026 | N-PORT |
| VMAX · Lattice Strategies Trust | 1,25% | 1.543 NS | 30 de Abril de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1,22% | 645.908 SH | 19 de Agosto de 2026 | Diário |
| CURE · Direxion Shares ETF Trust | 1,20% | 4.402 NS | 30 de Abril de 2026 | N-PORT |
| IMCV · iShares Trust | 1,14% | 34.017 SH | 21 de Agosto de 2026 | Diário |
| FTA · First Trust Exchange-Traded AlphaDE… | 1,12% | 38.663 NS | 30 de Abril de 2026 | N-PORT |
| SURE · AdvisorShares Trust | 1,09% | 1.600 NS | 30 de Junho de 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 1,09% | 1.312 NS | 30 de Abril de 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 1,06% | 278 NS | 31 de Maio de 2026 | N-PORT |
| IXJ · iShares Trust | 1,04% | 114.143 SH | 21 de Agosto de 2026 | Diário |
| MFSV · MFS Active Exchange Traded Funds Tr… | 1,04% | 12.508 NS | 31 de Maio de 2026 | N-PORT |
| PY · Principal Exchange-Traded Funds | 1,04% | 5.907 NS | 30 de Junho de 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,97% | 241.912 SH | 21 de Agosto de 2026 | Diário |
| RDVI · First Trust Exchange-Traded Fund IV | 0,96% | 78.591 NS | 30 de Abril de 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,96% | 5.883 NS | 30 de Abril de 2026 | N-PORT |
| ESMV · iShares Trust | 0,95% | 190 SH | 21 de Agosto de 2026 | Diário |
| GMOV · GMO ETF Trust | 0,93% | 2.152 NS | 31 de Maio de 2026 | N-PORT |
| EQIN · Columbia ETF Trust I | 0,90% | 6.636 NS | 30 de Abril de 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,77% | 12.014 NS | 30 de Abril de 2026 | N-PORT |
| NULC · Nushares ETF Trust | 0,73% | 1.105 NS | 30 de Abril de 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,73% | 15.896 SH | 19 de Agosto de 2026 | Diário |
| FCTR · First Trust Exchange-Traded Fund | 0,67% | 991 NS | 30 de Junho de 2026 | N-PORT |
| VLUE · iShares Trust | 0,67% | 164.189 SH | 21 de Agosto de 2026 | Diário |
| CVY · Invesco Exchange-Traded Fund Trust | 0,65% | 2.045 SH | 21 de Agosto de 2026 | Diário |
| FEUS · FlexShares Trust | 0,64% | 1.881 NS | 30 de Abril de 2026 | N-PORT |
| FDLO · FIDELITY COVINGTON TRUST | 0,62% | 23.028 NS | 30 de Abril de 2026 | N-PORT |
| COPY · RBB Fund Trust | 0,60% | 5.260 NS | 31 de Maio de 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 0,60% | 2.551 NS | 30 de Abril de 2026 | N-PORT |
| IDRV · iShares Trust | 0,58% | 129.150 SH | 21 de Agosto de 2026 | Diário |
| IMCB · iShares Trust | 0,56% | 24.206 SH | 21 de Agosto de 2026 | Diário |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,55% | 2.039 NS | 30 de Abril de 2026 | N-PORT |
| RDVY · First Trust Exchange-Traded Fund VI | 0,54% | 340.757 NS | 30 de Junho de 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,53% | 20.983 NS | 30 de Abril de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,51% | 12.437 SH | 21 de Agosto de 2026 | Diário |
| FNDX · SCHWAB STRATEGIC TRUST | 0,51% | 327.388 NS | 31 de Maio de 2026 | N-PORT |